Minimally Invasive Gastrointestinal Surgical Systems Market is anticipated to reach $10,441.0 million by 2031

The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031, growing at a CAGR of 6.8% during the forecast period 2021-2031.

Factors that can boost the growth of the market include advantages of minimally invasive surgical procedures over conventional open surgical procedures, availability of technological advanced products in the field of GI surgical procedures, increasing healthcare spending, and growth in robotics GI surgical procedures.

Surgeries for which minimally invasive gastrointestinal surgical systems can be used include Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, and Hernia Repair. End-users that use minimally invasive gastrointestinal surgical systems include hospitals, ambulatory surgical centers, and specialty clinics.

Key players operating in the market include Ambu A/S, B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cook Medical Inc., Intuitive Surgical, Inc., Olympus Corporation, Medtronic plc, Karl Storz SE & Co. KG, Stryker Corporation, Schölly Fiberoptic GmbH, Xenocor Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Richard Wolf GmbH, and TransEnterix, Inc.

Growth Drivers

• Advantages of Minimally Invasive Surgical Procedures Over Conventional Open Surgical Procedures

• Availability of Technological Advanced Products in the Field of GI Surgical Procedures

• Increasing Healthcare Spending

• Growth in Robotics GI Surgical Procedures

Market Challenges

• High Cost of Minimally Invasive GI Surgical Procedures

• Shortage of Skilled Professionals

• Restrictive Reimbursement Framework

Market Opportunities

• Development of Long-Distance Teleoperated Surgical Robotic Systems

• Mergers and Acquisitions to Diversify Endoscopic Portfolio

• Investment for Regional Expansion

Key Questions Answered in this Report:

•   What is the current market size and future potential of these products?
•   What is the current market share and growth share of the different products in the market?
•   What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive gastrointestinal surgical systems?
•   What are the major market drivers, restraints, and opportunities in the global minimally invasive gastrointestinal surgical systems market?
•   What is the impact of the COVID-19 pandemic on the market?
•   Which technology is being researched and worked upon to improve the gastrointestinal surgical systems?
•   Who are the leading players dominating the global minimally invasive gastrointestinal surgical systems market?
•   What are the key development and strategies incorporated by the players of global minimally invasive gastrointestinal surgical systems market, to sustain the competition and retain their supremacy?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive gastrointestinal surgical systems market?
•   How advanced technologies such as surgical robotics is gaining traction in terms of market share in in gastrointestinal space?

Request a Sample - https://bisresearch.com/requestsample?id=1072&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog